125 related articles for article (PubMed ID: 29528980)
21. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.
Shields CL; Kaliki S; Furuta M; Mashayekhi A; Shields JA
Retina; 2012 Jul; 32(7):1363-72. PubMed ID: 22466491
[TBL] [Abstract][Full Text] [Related]
22. Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.
Fry MV; Augsburger JJ; Corrêa ZM
JAMA Ophthalmol; 2019 Jan; 137(1):75-81. PubMed ID: 30422230
[TBL] [Abstract][Full Text] [Related]
23. Diffuse choroidal melanoma. Clinical features predictive of metastasis.
Shields CL; Shields JA; De Potter P; Cater J; Tardio D; Barrett J
Arch Ophthalmol; 1996 Aug; 114(8):956-63. PubMed ID: 8694731
[TBL] [Abstract][Full Text] [Related]
24. Iris melanoma: features and prognosis in 317 children and adults.
Shields CL; Kaliki S; Shah SU; Luo W; Furuta M; Shields JA
J AAPOS; 2012 Feb; 16(1):10-6. PubMed ID: 22370659
[TBL] [Abstract][Full Text] [Related]
25. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
26. Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.
Vichitvejpaisal P; Dalvin LA; Mazloumi M; Ewens KG; Ganguly A; Shields CL
Ophthalmology; 2019 Oct; 126(10):1445-1453. PubMed ID: 31026493
[TBL] [Abstract][Full Text] [Related]
27. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
28. [Clinical Analysis of Uveal Melanoma].
Nezu N; Goto H; Umazume K; Ueda S; Shibata M
Nippon Ganka Gakkai Zasshi; 2017 May; 121(5):413-8. PubMed ID: 30074750
[TBL] [Abstract][Full Text] [Related]
29. Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.
Shields CL; Welch RJ; Malik K; Acaba-Berrocal LA; Selzer EB; Newman JH; Mayro EL; Constantinescu AB; Spencer MA; McGarrey MP; Knapp AN; Graf AE; Altman AJ; Considine SP; Shields JA
Middle East Afr J Ophthalmol; 2018; 25(2):81-90. PubMed ID: 30122853
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
31. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
[TBL] [Abstract][Full Text] [Related]
32. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
[TBL] [Abstract][Full Text] [Related]
33. Prognosis in uveal melanoma with extrascleral extension.
Affeldt JC; Minckler DS; Azen SP; Yeh L
Arch Ophthalmol; 1980 Nov; 98(11):1975-9. PubMed ID: 7436829
[TBL] [Abstract][Full Text] [Related]
34. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
35. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control.
Mashayekhi A; Shields CL; Rishi P; Atalay HT; Pellegrini M; McLaughlin JP; Patrick KA; Morton SJ; Remmer MH; Parendo A; Schlitt MA; Shields JA
Ophthalmology; 2015 Mar; 122(3):600-9. PubMed ID: 25439431
[TBL] [Abstract][Full Text] [Related]
36. Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
Fabian ID; Tomkins-Netzer O; Stoker I; Arora AK; Sagoo MS; Cohen VM
Am J Ophthalmol; 2015 Dec; 160(6):1104-1110.e1. PubMed ID: 26344583
[TBL] [Abstract][Full Text] [Related]
37. Posterior uveal melanoma in young patients treated with proton beam therapy.
Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
[TBL] [Abstract][Full Text] [Related]
39. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
Quivey JM; Augsburger J; Snelling L; Brady LW
Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
[TBL] [Abstract][Full Text] [Related]
40. Uveal melanoma: management and outcome of patients with extraocular spread.
Bellmann C; Lumbroso-Le Rouic L; Levy C; Plancher C; Dendale R; Sastre-Garau X; Asselain B; Desjardins L
Br J Ophthalmol; 2010 May; 94(5):569-74. PubMed ID: 19965816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]